Revolution Medicines, Inc. RVMD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

45/100

1/6 Pass

SharesGrow Intrinsic Value

Revolution Medicines, Inc. (RVMD) has 20 known insider and institutional holders on record. The largest holder is Third Rock Ventures III, L.P. with 5,524,031 shares. Other notable holders include TEPPER ROBERT I and COLUMN GROUP III, LP.

Over the last 12 months, insiders have made 46 transactions in RVMD stock — 9 buys (valued at $38.84M) and 24 sells (valued at $8.31M). Insider selling has exceeded buying during this period.

RVMD Insider Ownership

Top Holder

Third Rock Ventures III, L.P.

5,524,031 shares

Buys (12 mo)

$38.84M value

Sells (12 mo)

$8.31M value

12-Month Transaction Activity

Buy 20%

Sell 52%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Third Rock Ventures Iii, L.p.	10 Percent Owner	5,524,031	2021-02-26	100%
2	Tepper Robert I	Director	5,104,130	2022-06-10	92%
3	Column Group Iii, Lp	10 Percent Owner	2,151,026	2020-11-18	39%
4	Svennilson Peter	Director	1,582,965	2021-04-28	29%
5	Schroeder Thilo	Director	760,869	2024-12-09	14%
6	Kelsey Stephen Michael	See Remarks	295,398	2026-03-19	5%
7	Goldsmith Mark A	See Remarks	276,698	2026-03-19	5%
8	Third Rock Ventures Ii, L.p.	10 Percent Owner	164,996	2021-06-07	3%
9	Horn Margaret A	Chief Operating Officer	157,570	2026-03-19	3%
10	Anders Jack	Chief Financial Officer	125,512	2026-03-19	2%
11	Wang Xiaolin	See Remarks	116,063	2026-03-19	2%
12	Wei Lin	Chief Medical Officer	101,366	2026-03-19	2%
13	Cislini Jeff	General Counsel	59,681	2026-03-19	1%
14	Mancini Anthony	See Remarks	54,400	2026-03-26	1%
15	Lasky Laurence	Director	36,168	2020-02-14	1%
16	Clyburn Frank	Director	26,540	2025-04-28	0%
17	Schmidt Eric Thomas	Director	18,400	2023-06-12	0%
18	Exter Neil	Director	18,400	2022-06-17	0%
19	Borisy Alexis	Director	15,955	2024-06-28	0%
20	Borellini Flavia	Director	15,955	2024-06-28	0%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-03-25	Mancini Anthony	See Remarks	Informative Sell	400	$97.21	$38.88K
2026-03-20	Mancini Anthony	See Remarks	Unknown	26,200	$102.02	$2.67M
2026-03-20	Sandler Alan B.	Chief Development Officer	Unknown	11,700	$102.02	$1.19M
2026-03-19	Cislini Jeff	General Counsel	Informative Sell	1,163	$97.44	$113.32K
2026-03-17	Cislini Jeff	General Counsel	Informative Sell	1,795	$99.48	$178.57K
2026-03-17	Wei Lin	Chief Medical Officer	Informative Sell	2,073	$99.48	$206.22K
2026-03-17	Wang Xiaolin	See Remarks	Informative Sell	2,010	$99.48	$199.96K
2026-03-17	Anders Jack	Chief Financial Officer	Informative Sell	2,753	$99.48	$273.87K
2026-03-17	Kelsey Stephen Michael	See Remarks	Informative Sell	4,302	$99.48	$427.96K
2026-03-17	Horn Margaret A	Chief Operating Officer	Informative Sell	4,583	$99.48	$455.92K
2026-03-17	Goldsmith Mark A	See Remarks	Informative Sell	12,871	$99.48	$1.28M
2026-03-04	Anderson Elizabeth M	Director	Gift (Given)	15,000	-	-
2026-03-01	Cislini Jeff	General Counsel	RSU Award	32,500	$102.02	$3.32M
2026-03-01	Wei Lin	Chief Medical Officer	RSU Award	34,000	$102.02	$3.47M
2026-03-01	Wang Xiaolin	See Remarks	RSU Award	34,000	$102.02	$3.47M
2026-03-01	Anders Jack	Chief Financial Officer	RSU Award	45,400	$102.02	$4.63M
2026-03-01	Kelsey Stephen Michael	See Remarks	RSU Award	47,600	$102.02	$4.86M
2026-03-01	Horn Margaret A	Chief Operating Officer	RSU Award	47,600	$102.02	$4.86M
2026-03-02	Goldsmith Mark A	See Remarks	Option Exercise (Sell)	30,000	$4.09	$122.7K
2026-03-01	Goldsmith Mark A	See Remarks	RSU Award	128,600	$102.02	$13.12M
2026-02-06	Goldsmith Mark A	See Remarks	Option Exercise (Sell)	24,010	$0.54	$12.97K
2026-01-21	Cislini Jeff	General Counsel	Informative Sell	908	$115.60	$104.96K
2026-01-07	Anders Jack	Chief Financial Officer	Option Exercise (Sell)	10,000	$42.45	$424.5K
2026-01-07	Horn Margaret A	Chief Operating Officer	Option Exercise (Sell)	51,406	$42.45	$2.18M
2025-12-16	Cislini Jeff	General Counsel	Informative Sell	2,688	$76.82	$206.48K